Stock 4530 HISAMITSU PHARMACEUTICAL CO., INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Hisamitsu Pharmaceutical Co., Inc.

Equities

4530

JP3784600003

Market Closed - Japan Exchange
Other stock markets
 07:00:00 02/05/2024 BST 		5-day change 1st Jan Change
3,740 JPY -2.07% Intraday chart for Hisamitsu Pharmaceutical Co., Inc. -1.03% -13.25%
04-11 Hisamitsu Pharmaceutical Attributable Profit Up 19% in Fiscal 2024 MT
01-12 Hisamitsu Pharmaceutical Lifts Fiscal-Year Targets as Nine-Month Profit, Net Sales Rise MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Hisamitsu Pharmaceutical Attributable Profit Up 19% in Fiscal 2024
Hisamitsu Pharmaceutical Lifts Fiscal-Year Targets as Nine-Month Profit, Net Sales Rise
Hisamitsu Pharmaceutical Co., Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending February 29, 2024
Hisamitsu Pharmaceutical Co., Inc. Announces Dividend for the Second Quarter and Provides Dividend Guidance for the Full Year Ending February 29, 2024
Hisamitsu Pharmaceutical’s Attributable Profit up 29.4% in Fiscal Q2 on Improved Net Sales
Hisamitsu Pharmaceutical Co., Inc. Reports Earnings Results for the Half Year Ended August 31, 2023
Hisamitsu Pharmaceutical Attributable Profit More Than Doubles in Fiscal Q1; Shares Climb 11%
Hisamitsu Pharmaceutical Co., Inc. announces an Equity Buyback for 2,000,000 shares, for ¥10,000 million.
Hisamitsu Pharmaceutical Co., Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending February 29, 2024
Hisamitsu Pharmaceutical Co., Inc. Provides Dividend Guidance for the Second Quarter of Fiscal 2024 and Full Year Ending February 29, 2024
Hisamitsu Pharmaceutical Co., Inc. authorizes a Buyback Plan.
Hisamitsu Pharmaceutical Affirms Final Dividend on Higher FY23 Profit, Revenue
Hisamitsu Pharmaceutical Co., Inc. Announces Dividend for the Year 2023, Effective May 26, 2023
Hisamitsu Pharmaceutical Co., Inc. Provides Dividend Guidance for the Second Quarter of Fiscal 2024 and Full Year Ending February 29, 2024
Hisamitsu Pharmaceutical Co., Inc. Announces Special Dividend for the Fiscal Year 2023
Hisamitsu Pharmaceutical Co., Inc. Provides Consolidated Earnings Guidance for the Year Ending February 29, 2024
Hisamitsu Pharmaceutical Co., Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending February 28, 2023
Hisamitsu Pharmaceutical Co., Inc. Provides Special Dividend Guidance for the Fiscal Year 2023
Hisamitsu Pharmaceutical Co., Inc. Provides Year End Dividend Guidance for the Fiscal Year Ending February 28, 2023
Japan Equities Slide Further; Hisamitsu Pharmaceutical Soars 14% on Fiscal H1 Attributable Profit Growth
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4530 Stock
  4. News Hisamitsu Pharmaceutical Co., Inc.
  5. Other languages